Prosecution Insights
Last updated: April 19, 2026

Immunological And Medicinal Products Sl

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17767096 Use of an anti-CCR7 antibody in combination therapies with a BTK inhibitor and/or BCL2- inhibitor for treating hematological malignancies ALLEN, MARIANNE P 1647 Non-Final OA Apr 07, 2022

Managing Immunological And Medicinal Products Sl's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month